Regolo research finds 75% of EU businesses expose customer data to foreign surveillance.
The Story
This highlights a significant vulnerability in data handling practices across European companies.
Why It Matters
This isn't just a headline; it's a ticking clock for regulated EU pharma. Your data, your patients' data, is likely at risk. The upcoming EU AI Act isn't just about AI models; it's about the entire data lifecycle. Ignoring this now means compliance headaches later.
What To Do About It
I can audit your current data architecture and identify foreign exposure risks, preparing you for EU AI Act compliance and securing your valuable pharma data.
Sources
Related Signals
Flagright, a new AI operating system for compliance, just secured $12.5M in funding.
17 Jun 2026
Pharma compliance is actively adapting to new AI tools and emerging regulation.
6 Jun 2026
Weverse Brain was selected for South Korea's Ministry of Science and ICT's "Advanced GPU Utilization Support Project".
2 Jun 2026